SAN DIEGO, Sept. 1, 2022 /PRNewswire/ -- Cue Health ("Cue") (NASDAQ: HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for fullSAN DIEGO, Sept.
Snowflake Inc. (NYSE: SNOW) surged 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance.
SAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ: HLTH) announced today the preprint publication of an independent clinical study - the largest of itsSAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ -- Cue Health Inc.